CRISM Therapeutics Corporation
Status: Publicly traded
Direct answer
CRISM Therapeutics Corporation is publicly traded on LSE under the ticker CRTX.L.
CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology...
Can you invest in CRISM Therapeutics Corporation?
Yes. CRISM Therapeutics Corporation is publicly traded on LSE under the ticker CRTX.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CRISM Therapeutics Corporation
Detailed equity research is provided by MarketSnap.